Alexandra Prufer de Queiroz Campos Araújo

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli et al. · The Lancet · 2017 · 446 citations · Full text

Rare Diseases, Urology, Clinical Trials +5

Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy

Alexandra Prufer de Queiroz Campos Araújo, Mário Lúcio Cordeiro Araújo, Kathryn J. Swoboda · The Journal of Pediatrics · 2009 · 126 citations

Pediatrics, Vascular Malformation, Vascular Perfusion Abnormalities +4

Timed motor function tests capacity in healthy children

Aline Chacon Pereira, Márcia Gonçalves Ribeiro, Alexandra Prufer de Queiroz Campos Araújo · Archives of Disease in Childhood · 2015 · 54 citations · Full text

Intragenic variants in the <i>SMN1</i> gene determine the clinical phenotype in 5q spinal muscular atrophy

Rodrigo de Holanda Mendonça, Ciro Matsui, Graziela Jorge Polido et al. · Neurology Genetics · 2020 · 42 citations · Full text

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Fernanda Pinto‐Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer de Queiroz Campos Araújo et al. · Skeletal Muscle · 2015 · 29 citations · Full text